AEON Biopharma, Inc.
AEON
$0.24
$0.000.21%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.99M | 3.90M | 3.49M | 2.33M | 3.26M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.93M | 5.94M | 5.10M | 2.93M | 4.32M |
| Operating Income | -5.93M | -5.94M | -5.10M | -2.93M | -4.32M |
| Income Before Tax | -1.16M | -11.79M | -37.14M | -4.54M | -6.64M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.16M | -11.79M | -37.14M | -4.54M | -6.64M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.16M | -11.79M | -37.14M | -4.54M | -6.64M |
| EBIT | -5.93M | -5.94M | -5.10M | -2.93M | -4.32M |
| EBITDA | -5.91M | -5.92M | -5.08M | -2.91M | -4.30M |
| EPS Basic | -0.02 | -0.29 | -2.88 | -0.39 | -0.60 |
| Normalized Basic EPS | -0.01 | -0.05 | -0.93 | -0.17 | -0.27 |
| EPS Diluted | -0.02 | -0.29 | -2.88 | -0.39 | -0.60 |
| Normalized Diluted EPS | -0.01 | -0.05 | -0.93 | -0.17 | -0.27 |
| Average Basic Shares Outstanding | 50.53M | 40.61M | 12.89M | 11.63M | 11.09M |
| Average Diluted Shares Outstanding | 50.53M | 40.61M | 12.89M | 11.63M | 11.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |